Could this biotech spark Big Pharma's next multibillion-dollar
move? ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏



 

_You are receiving this email because you are subscribed to MORNING
WATCHLIST FROM BEHIND THE MARKETS. If you no longer wish to receive
these partner emails, please unsubscribe
[[link removed]]
here. This message is from Edge on the Street._

-------------------------

This patented biotech platform could power 100's of cancer drugs.
See
who:....                              

[[link removed]]

The $43B Big Pharma Blueprint

Big Pharma once paid $43B to acquire a small biotech with similar
technology. Now, a new company is following that same
playbook...backed by patents, data, and early-stage traction. If
history repeats, this could be one of the most interesting biotech
stories this year.

Find out who's executing this early-stage excitement
[[link removed]]

We are issuing this disclosure in compliance with Section 17(b) of the
Securities Act, which requires us to disclose any compensation
received or expected to be received in cash or in kind in connection
with the purchase or sale of any security.

We would like to inform you that we have received or expect to receive
compensation in connection with the purchase or sale of the securities
of Defence Therapeutics (OTC: DTCFF). The compensation consists of up
to $5,500 and was received/will be received from i2i Marketing Group.

This communication should not be considered as an endorsement of the
securities of adviser Defence Therapeutics (OTC: DTCFF) and we are not
responsible for any errors or omissions in any information provided
about the securities of Defence Therapeutics (OTC: DTCFF) by Edge on
the Street or i2i Merketing Group.

We encourage you to conduct your own due diligence and research before
making any investment decisions. You should also consult with a
financial advisor before making any investment decisions.

This disclosure is made as of 12/03/2025.

Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431

Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the
Markets. For more information about our privacy practices, please
review our Privacy Policy
[[link removed]]
or our Legal Notices.
[[link removed]]

Behind the Markets
[[link removed]]

_You are receiving this email because you are subscribed to Morning
Watchlist from Behind the Markets. If you no longer wish to receive
these partner emails, please unsubscribe here
[[link removed]]._

TODAY'S BONUS CONTENT: 3 Dirt-Cheap Stocks You Can’t Afford to
Ignore
[[link removed]]

_(By clicking this link you agree to receive emails from Trading Tips
and our affiliates. You can opt out at any time. -__ __Privacy
Policy)_ [[link removed]]